Table of Contents
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Abdominal Aortic Stent Grafts Overview 9
3 Products under Development 10
3.1 Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 10
3.2 Abdominal Aortic Stent Grafts – Pipeline Products by Territory 11
3.3 Abdominal Aortic Stent Grafts – Pipeline Products by Regulatory Path 12
3.4 Abdominal Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 13
3.5 Abdominal Aortic Stent Grafts – Ongoing Clinical Trials 14
4 Abdominal Aortic Stent Grafts – Pipeline Products under Development by Companies 15
4.1 Abdominal Aortic Stent Grafts Companies – Pipeline Products by Stage of Development 15
4.2 Abdominal Aortic Stent Grafts – Pipeline Products by Stage of Development 16
5 Abdominal Aortic Stent Grafts Companies and Product Overview 18
5.1 Affluent Medical SA Company Overview 18
5.1.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Altura Medical Inc Company Overview 21
5.2.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Angiolutions UG Company Overview 24
5.3.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Aortica Corp Company Overview 25
5.4.1 Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 BiFlow Medical Ltd Company Overview 26
5.5.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Cook Medical Inc Company Overview 27
5.6.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Cordis Corp Company Overview 31
5.7.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Cytograft Tissue Engineering Inc (Inactive) Company Overview 35
5.8.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 Endologix Inc Company Overview 36
5.9.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Endoluminal Sciences Pty Ltd. Company Overview 51
5.10.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
5.11 Hadassah Medical Center Company Overview 52
5.11.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 JOTEC GmbH Company Overview 53
5.12.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Kawasumi Laboratories Inc Company Overview 56
5.13.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.14 Lombard Medical Technologies Inc. Company Overview 57
5.14.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.15 Lombard Medical Technologies Ltd Company Overview 58
5.15.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
5.16 Medtronic plc Company Overview 64
5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 64
5.17 St. Jude Medical LLC Company Overview 67
5.17.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 67
5.18 Terumo Aortic Company Overview 68
5.18.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 68
5.19 University of Colorado Denver Company Overview 76
5.19.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 76
5.20 University of Limerick Company Overview 77
5.20.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 77
5.21 Venus MedTech Company Overview 78
5.21.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 78
5.22 W. L. Gore & Associates Inc Company Overview 79
5.22.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 79
6 Abdominal Aortic Stent Grafts- Recent Developments 84
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
6.3 Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium 87
6.4 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 88
6.5 Nov 06, 2019: Endologix reports third quarter 2019 financial results 88
7 Appendix 130
7.1 Methodology 130
7.2 About GlobalData 133
7.3 Contact Us 133
7.4 Disclaimer 133
Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 8: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Kardiozis - Product Status
Table 10: Kardiozis - Product Description
Table 11: Affluent Medical SA - Ongoing Clinical Trials Overview
Table 12: Kardiozis - Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination with Coil Embolisation of the Aneurysmal Sac
Table 13: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Altura Endograft System - Product Status
Table 15: Altura Endograft System - Product Description
Table 16: Altura Medical Inc - Ongoing Clinical Trials Overview
Table 17: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion: ELEVATE International
Table 18: Altura Endograft System - Multi-center Observational Post-market Real World Registry
Table 19: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms
Table 20: Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Vascular Graft (A3-Shield) - Product Status
Table 22: Vascular Graft (A3-Shield) - Product Description
Table 23: Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: BoulEVARd Stent - Product Status
Table 25: BoulEVARd Stent - Product Description
Table 26: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status
Table 28: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description
Table 29: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Zenith p-Branch - Product Status
Table 31: Zenith p-Branch - Product Description
Table 32: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 33: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
Table 34: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion
Table 35: Zenith p-Branch - Zenith p-Branch Multi-center Study
Table 36: Zenith p-Branch - Zenith p-Branch Pivotal Study
Table 37: Zenith p-Branch - Zenith p-Branch: Single-center Study
Table 38: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: INCRAFT AAA Stent Graft - Product Status
Table 40: INCRAFT AAA Stent Graft - Product Description
Table 41: Cordis Corp - Ongoing Clinical Trials Overview
Table 42: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms: INSPIRATION
Table 43: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
Table 44: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post-market Study of the INCRAFT AAA Stent Graft in Subjects with Abdominal Aortic Aneurysms
Table 45: INCRAFT AAA Stent Graft - Korean Registry of Percutaneous EVAR with INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
Table 46: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 47: LifeJacket AAA Stent Graft - Product Status
Table 48: LifeJacket AAA Stent Graft - Product Description
Table 49: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: AFX2 Bifurcated Endograft System - Product Status
Table 51: AFX2 Bifurcated Endograft System - Product Description
Table 52: AFX3 - Product Status
Table 53: AFX3 - Product Description
Table 54: AFX4 - Product Status
Table 55: AFX4 - Product Description
Table 56: Nellix 3.5 - Product Status
Table 57: Nellix 3.5 - Product Description
Table 58: Nellix CHEVAS - Product Status
Table 59: Nellix CHEVAS - Product Description
Table 60: Nellix EVAS System - Product Status
Table 61: Nellix EVAS System - Product Description
List of Figures
Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer